1. Home
  2. CERS vs MCFT Comparison

CERS vs MCFT Comparison

Compare CERS & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • MCFT
  • Stock Information
  • Founded
  • CERS 1991
  • MCFT 1968
  • Country
  • CERS United States
  • MCFT United States
  • Employees
  • CERS N/A
  • MCFT N/A
  • Industry
  • CERS EDP Services
  • MCFT Marine Transportation
  • Sector
  • CERS Technology
  • MCFT Industrials
  • Exchange
  • CERS Nasdaq
  • MCFT Nasdaq
  • Market Cap
  • CERS 286.0M
  • MCFT 317.3M
  • IPO Year
  • CERS 1997
  • MCFT 2015
  • Fundamental
  • Price
  • CERS $1.81
  • MCFT $18.69
  • Analyst Decision
  • CERS Buy
  • MCFT Buy
  • Analyst Count
  • CERS 3
  • MCFT 4
  • Target Price
  • CERS $3.17
  • MCFT $20.75
  • AVG Volume (30 Days)
  • CERS 1.4M
  • MCFT 84.2K
  • Earning Date
  • CERS 03-04-2025
  • MCFT 02-05-2025
  • Dividend Yield
  • CERS N/A
  • MCFT N/A
  • EPS Growth
  • CERS N/A
  • MCFT N/A
  • EPS
  • CERS N/A
  • MCFT N/A
  • Revenue
  • CERS $176,229,000.00
  • MCFT $337,642,000.00
  • Revenue This Year
  • CERS $21.42
  • MCFT N/A
  • Revenue Next Year
  • CERS $11.12
  • MCFT $15.63
  • P/E Ratio
  • CERS N/A
  • MCFT N/A
  • Revenue Growth
  • CERS 14.71
  • MCFT N/A
  • 52 Week Low
  • CERS $1.38
  • MCFT $16.12
  • 52 Week High
  • CERS $2.59
  • MCFT $24.05
  • Technical
  • Relative Strength Index (RSI)
  • CERS 57.20
  • MCFT 48.33
  • Support Level
  • CERS $1.74
  • MCFT $18.25
  • Resistance Level
  • CERS $1.87
  • MCFT $18.94
  • Average True Range (ATR)
  • CERS 0.10
  • MCFT 0.67
  • MACD
  • CERS 0.03
  • MCFT 0.10
  • Stochastic Oscillator
  • CERS 79.49
  • MCFT 53.72

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: